The abnormal accumulation of activated Lyn kinase caused by chorein protein deficiency has been proven to be responsible for part of pathological phenotypes of ChAc, and it is a potential therapeutic target to treat ChAc. This evidence concerns the gene VPS13A and Choreoacanthocytosis.